Bone marrow infiltration by cells resembling plasmablasts in a patient with blastic plasmacytoid dendritic cell neoplasm
Tóm tắt
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy derived from clonal proliferation of plasmacytoid dendritic cells. The disease has two patterns of presentation: cutaneous and leukemic. Herein we describe the case of a 9-year-old boy who presented with an unusual morphologic variant of leukemic BPDCN, showing bone marrow infiltration by medium to large cells with eccentric nuclei, regular round to oval shape, finely dispersed chromatin, one or more distinct nucleoli, and abundant basophilic cytoplasm, forming a pattern that resembled plasmablasts. Multiparameter flow cytometric immunophenotyping confirmed the diagnosis of BPDCN by identifying the expression of CD4++, CD56++, HLA-DR+++, and CD123+++ in abnormal cells, without significant expression of myeloid or lymphoid lineage-specific markers. Awareness of this plasmablastic variant of BPCDN can be helpful for directing the flow cytometry panel and the subsequent investigation of patients presenting with bone marrow infiltration by cells with plasmablastic features.
Tài liệu tham khảo
Facchetti F (2011) Blastic plasmacytoid dendritic cell neoplasm. In: Jaffe ES, Harris NL, Vardiman JW, Campo E, Arber DA (eds) Hematopathology, 1st edn. Saunders, St. Louis, pp 788–798
Jegalian AG, Buxbaum NP, Facchetti F, Raffeld M, Pittaluga S, Wayne AS, Jaffe ES (2010) Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica 95(11):1873–1879
Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dompmartin A, d'Incan M, Maubec E, Grange F, Dereure O, Prey S, Barete S, Wetterwald M, Fraitag S, Petrella T (2010) Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol 162(1):74–79
Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drénou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, Le Calvez G, Sainty D, Sotto MF, Trimoreau F, Béné MC (2002) Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 99(5):1556–1563
Tsagarakis NJ, Kentrou NA, Papadimitriou KA, Pagoni M, Kokkini G, Papadaki H, Pappa V, Marinakis T, Anagnostopoulos NI, Vadikolia C, Anagnostopoulos A, Angelopoulou MK, Terpos E, Poziopoulos C, Anargyrou K, Rontogianni D, Papadaki T, Psarra A, Kontopidou FN, Skoumi D, Papadhimitriou SI, Hellenic Dendritic Cell Leukemia Study Group (2010) Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group. Leuk Res 34(4):438–446
Lee CK, Ma ES, Shek TW, Lam CC, Au WY, Wan TS, Chan LC (2003) Plasmablastic transformation of multiple myeloma. Hum Pathol 34(7):710–714
Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ (1997) The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185(6):1101–1111